POLE and cancer: The human colon carcinoma cell line HT115 possesses a missense mutation in one copy of the DNA polymerase epsilon (POLE) gene, specifically a V411L mutation in the exonuclease domain which has been associated with hypermutated cancer phenotypes (Barretina et al. 2012; Forbes et al. 2015).